Disease types and treatment suggestions for Valganciclovir

Valganciclovir (Valganciclovir) is an oral antiviral drug, a nucleoside viral DNA polymerase inhibitor, mainly used to prevent and treat cytomegalovirus (CMV) infection. It is rapidly converted into ganciclovir (Ganciclovir) in the body, and achieves effective control of CMV by inhibiting the replication of virus DNA. Vansevit is convenient to take orally and has high bioavailability. It is widely used in people with low immune function, such as organ transplant patients, hematopoietic stem cell transplant patients and AIDS patients.

In organ transplant patients, Vancevir is mainly used to prevent and treat CMV infection, especially in high-risk transplant patients (such as donors CMV positive and recipients CMV negative). Clinically, prophylactic oral therapy is often started weeks to months after transplantation and usually lasts for 3 to 6 months to reduce the risk of CMV infection and related complications. For patients who have already developed CMV infection or disease, a treatment plan can be formulated based on blood viral load and clinical symptoms. A higher dose course of treatment is usually used to quickly suppress viral replication.

In addition, Vancevir is also suitable for other patients with low immune function, such as HIV infected patients who develop CMVretinitis or CMVemia. The dose can be adjusted according to the viral load and the patient's immune status. During treatment, blood routine, liver and kidney function, and viral load should be closely monitored, and the dose should be adjusted in a timely manner to reduce the risk of adverse drug reactions. Side effects mainly include hematological suppression (such as neutropenia, anemia, thrombocytopenia), abnormal liver and renal function, and mild gastrointestinal discomfort.

In general, Vancevir is effective in CMV infection and prevention and is convenient to take orally. It is an important antiviral drug for patients with low immune function. When using it, you should strictly follow the dosage and treatment course prescribed by the doctor, and make individual adjustments based on hematology and virus monitoring. Rational use of Vancevir can not only effectively reduce the CMV infection rate, but also improve the overall prognosis of patients after surgery or in chronic immunosuppression.

Reference materials:https://www.drugs.com/